Sarah J. Moore

Principal Investigator

Associate Professor

Picker Engineering Program

Courtesy Appointment: Biological Sciences

Sarah Moore teaches and conducts research at the intersection of engineering and biology. Her research focuses on biomolecular engineering, primarily engineering proteins for applications in medicine. Current research in the Moore Lab includes engineering proteins for diagnosing and treating cancer, synthesizing protein-polymer conjugates for biomedical applications (collaboration with Maren Buck in Chemistry at Smith College), and developing methods to enable protein targeting ligands to deliver small molecule drugs.

Her Ph.D. research included engineering highly stable proteins for molecular imaging of cancer, for improved detection and surgical resection.

Sarah joined the faculty at Smith College in 2012. She has previously taught Engineering for Everyone; Fundamental Engineering Principles; Introduction to Biomedical Engineering; and Engineering and Cancer. Students who have conducted research in the Moore Lab come from a variety of majors, including engineering, biological sciences, biochemistry, chemistry and neuroscience.

Whenever possible, Sarah enjoys spending time outside with her family, including hiking, cycling, backpacking, snowshoeing, and rock climbing.  You might see her around campus with her wonderful kindergarten son, Michael.

Education

Ph.D., M.S., Bioengineering, Stanford University

B.S.E., Chemical Engineering, Princeton University

Selected Honors and Awards

Selected Publications

*Indicates undergraduate co-author.

A.R. Sirois, D.A. Deny*, Y Li*, Y.D. Fall*, S.J. Moore. Engineered Fn3 protein has targeted therapeutic effect on mesothelin-expressing cancer cells and increases tumor cell sensitivity to chemotherapy. Biotechnology and Bioengineering, 2019https://doi.org/10.1002/bit.27204

J.S. Kim*, A.R. Sirois, A.J. Vazquez Cegla*, E. Jumai’an*, N. Murata*, M.E. Buck, S.J. Moore. Protein-polymer conjugates synthesized using water-soluble azlactone-functionalized polymers enable receptor-specific cellular uptake towards targeted drug delivery.  Bioconjugate Chemistry, 2019. 30(4): 1220-1231.  https://pubs.acs.org/doi/10.1021/acs.bioconjchem.9b00155

A.R. Sirois, D.A. Deny*, S.R. Baierl*, K.S. George*, S.J. Moore. “Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding.” PLoS One, 2018. 13(5): e0197029. https://doi.org/10.1371/journal.pone.0197029. 

S.J. Moore, M.G. Hayden Gephart, J.M. Bergen, Y.S. Su, H. Rayburn, M.P. Scott, J.R. Cochran. “Engineered knottin peptide enables non-invasive optical imaging of intracranial medulloblastoma.” Proc. Natl. Acad. Sci. USA, 2013. 110(36): 14598-14603.

S.J. Moore, C.L. Leung, H.K. Norton*, and J.R. Cochran. “Engineering Agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.” PLOS ONE, 2013. 8: e60498.

H. Jiang, S.J. Moore, S. Liu, H. Liu, Z. Miao, F.V. Cochran, Y. Liu, M. Tian, J.R. Cochran, H. Zhang, and Z. Cheng. “A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging.” Amino Acids, 2013. DOI: 10.1007/s00726-012-1391-y.

S.J. Moore and J.R. Cochran. “Engineering Knottins as Novel Binding Agents.” Methods in Enzymology, 2012. 503: 223-251.

S.J. Moore, C.L. Leung, and J.R. Cochran. “Knottins: Disulfide-bonded Therapeutic and Diagnostic Peptides.” Drug Discovery Today: Technologies, 2012. 9: e3-e11.